IDH.L Regulatory News (IDH)

14 September 2012

Immunodiagnostic Systems Holdings PLC

AGM Results

Immunodiagnostic Systems Holdings PLC ("IDS" or "the Company" or "the Group"), a leading producer of manual and automated specialist diagnostic testing kits and instrumentation for the clinical and research markets, today announces the results of its Annual General Meeting (the "Meeting") that was held at noon.

Trading update

Dr Anthony Martin, Non-executive Chairman, provided a business update at the Meeting and a copy of the trading statement has been made available on the Company's website.

Voting Results

All of the Resolutions that were included in the Notice of the Meeting issued to shareholders on 9 August 2012, other than Resolution 3, were duly passed on a show of hands by shareholders at the Meeting held earlier today.

Upon the declaration of the result of the voting on a show of hands on Resolution 3, in accordance with the Articles of Association of the Company, a poll was duly demanded on the Resolution. A poll was conducted and the result of the poll on the Resolution was 6,897,463 votes in favour of the Resolution (equating to 46.32% of the votes cast) and 7,988,674 votes against the Resolution (equating to 53.68% of the votes cast) with no abstentions.Resolution 3 was therefore not passed by shareholders at the Meeting.

As a consequence of Resolution 3 not being passed at the Meeting, Roger Duggan, having retired from office and offered himself for re-appointment in accordance with the Articles of Association of the Company, was not re-appointed as a Director of the Company at the Meeting. Pursuant to the Articles of Association of the Company, Roger Duggan ceased to hold office on the Board of Directors of the Company from the conclusion of the Meeting earlier today.

Proxy Voting Results

Details of the proxies received by the Company before today's Meeting in respect of each resolution are listed below.

Ordinary Resolutions

1. To receive and adopt the Company's annual accounts for the financial year ended 31 March 2012 together with the Directors' and Auditor's report on those accounts and the corporate governance statement included therein.

2. To declare a final dividend of 2.75p per Ordinary share of 2p payable to shareholders on the register at the close of business on 7 September 2012.

3. To re-appoint Dr Roger Duggan, who retires by rotation, as a Director of the Company.

4. To appoint Dr Anthony Martin, who retires having been appointed since the date of the last AGM, as a Director of the Company.

5. To appoint Mr Gerard Murray, who retires having been appointed since the date of the last AGM, as a Director of the Company.

6. To appoint Ernst & Young LLP as auditor of the Company to hold office from the conclusion of the meeting until the conclusion of the next meeting at which the accounts are laid before the Company at remuneration to be determined by the Directors.

7. To approve the Directors' remuneration report for the financial year ended 31 March 2012.

8. To authorise the Directors of the Company to allot shares in the Company or grant rights to subscribe for or convert any security into shares in the Company pursuant to section 551 of the Companies Act 2006, subject to the restrictions set out in the notice of Meeting.

Special Resolution

9. To authorise the Directors of the Company to disapply statutory pre-emption rights pursuant to Section 570 of the Companies Act 2006, subject to the restrictions set out in the notice of Meeting.

1. A vote 'Withheld' is not a vote in law and is not counted in the calculation of the proportion of votes 'For' and 'Against' a resolution.

For further information: